Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and piperazine

quinazolines has been researched along with piperazine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatnagar, PK; Chaira, T; Cliffe, I; Das, B; Dastidar, SG; Diwan, M; Gupta, P; Kumar, A; Malik, R; Malik, S; Nithya, D; Pamidiboina, V; Ray, A; Senthil, V; Tandon, R; Venkataramanan, R1
Cagnotto, A; Intagliata, S; Modica, MN; Pittalà, V; Romeo, G; Salerno, L; Salmona, M; Siracusa, MA1
Cai, R; Chen, S; Cheng, Y; Du, L; Han, B; Li, M; Lin, Y; Ma, Z; Shi, B; Shi, X; Wu, W; Zhou, Y1

Other Studies

3 other study(ies) available for quinazolines and piperazine

ArticleYear
RBx10080307, a dual EGFR/IGF-1R inhibitor for anticancer therapy.
    European journal of pharmacology, 2013, Jul-05, Volume: 711, Issue:1-3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Resistance, Neoplasm; Drug Stability; ErbB Receptors; Erlotinib Hydrochloride; Female; HT29 Cells; Humans; Male; Membrane Potential, Mitochondrial; Mice; Microsomes, Liver; Mutation; Phosphorylation; Piperazine; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Quinazolines; Receptor, IGF Type 1; Signal Transduction; Xenograft Model Antitumor Assays

2013
Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands.
    Bioorganic & medicinal chemistry letters, 2015, Apr-01, Volume: 25, Issue:7

    Topics: Binding Sites; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Piperazine; Piperazines; Pyrimidines; Quinazolines; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Structure-Activity Relationship

2015
Discovery of the First Environment-Sensitive Near-Infrared (NIR) Fluorogenic Ligand for α1-Adrenergic Receptors Imaging in Vivo.
    Journal of medicinal chemistry, 2016, Mar-10, Volume: 59, Issue:5

    Topics: Animals; Binding Sites; Carbocyanines; Cell Line, Tumor; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Drug Discovery; Fluorescence; Fluorescent Dyes; HEK293 Cells; Humans; Ligands; Mice; Molecular Structure; Neoplasms, Experimental; Piperazine; Piperazines; Quinazolines; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship

2016